Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/47172
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPattraporn Chera-Areeen_US
dc.contributor.authorChenchit Chayachindaen_US
dc.contributor.authorSuvimol Niyomnaithamen_US
dc.contributor.authorWitchuda Kamolviten_US
dc.contributor.otherKarolinska University Hospitalen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2019-08-28T06:35:54Z-
dc.date.available2019-08-28T06:35:54Z-
dc.date.issued2018-01-01en_US
dc.identifier.citationSiriraj Medical Journal. Vol.70, No.6 (2018), 479-483en_US
dc.identifier.issn22288082en_US
dc.identifier.other2-s2.0-85059521320en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059521320&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/47172-
dc.description.abstract© 2018 Siriraj Medical Journal. Objective: To compare length of hospital stay (LOS) and surgical rate in patients hospitalized with pelvic inflammatory disease (PID) who received either cefoxitin plus doxycycline regimen or clindamycin plus gentamicin regimen. Methods: Medical records of patients hospitalized with PID from 2004 to 2011 were reviewed. Study population was women aged 14-40 years old who had a first-time, admitted diagnosis and a discharged diagnosis of PID. Patients who had prior hysterectomy, bilateral salpingectomy and were not sexually active were excluded. The patients received either intravenous cefoxitin (2 grams every 6 hours) plus oral doxycycline (100 mg twice a day) regimen or intravenous clindamycin (900 mg every 8 hours) plus gentamicin (240 mg once daily) regimen. Outcomes of interest were LOS and surgical rate. Results: Of 252 eligible participants, 141 (55.95%) received cefoxitin plus doxycycline and 111 (44.05%) received clindamycin plus gentamicin. The patients receiving cefoxitin plus doxyclycline had statistically significant lower age and less number of cases of tubo-ovarian abscess (TOA) (P < 0.05). Logistic regression showed the similar LOS and surgical rate in both groups after adjusted with age and TOA. No severe adverse effect was identified in both regimens. Conclusion: Cefoxitin plus doxycycline regimen appears as effective as clindamycin plus gentamicin regimen for treating hospitalized PID patients in terms of LOS, surgical rate and safety profile.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059521320&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCefoxitin plus doxycycline versus clindamycin plus gentamicin in hospitalized pelvic inflammatory disease patients: An experience from a tertiary hospitalen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.14456/smj.2018.77en_US
Appears in Collections:Scopus 2018

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.